MYC and lymphoma: The combination of ABT‐737 and low‐dose cyclophosphamide in MYC and BCL‐2‐deregulated tumors was previously tested by Mason et al. They showed that most (14/18) C57BL/6 mice transplanted with Eμmyc/EμBCL‐2 lymphomas and treated with this combination therapy achieved complete remission [34].